SMTL ID : 3ms9.1 (1 other biounit)

ABL kinase in complex with imatinib and a fragment (FRAG1) in the myristate pocket

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x STI: 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE(Non-covalent)

STI.1: 23 residues within 4Å: Chain A: L.26, Y.31, V.34, A.47, K.49, E.64, V.67, M.68, I.71, V.77, I.91, T.93, F.95, M.96, I.138, H.139, R.140, L.148, A.158, D.159, F.160 Ligands: CL.4, CL.6 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:L.26, A:Y.31, A:V.34, A:A.47, A:E.64, A:I.71, A:I.91, A:T.93, A:L.148, A:D.159, A:F.160 Hydrogen bonds: A:E.64, A:E.64, A:T.93, A:M.96, A:D.159 pi-Stacking: A:Y.31 pi-Cation interactions: A:H.139

1 x MS9: methyl 2-amino-4-chlorobenzoate(Non-covalent)

MS9.2: 10 residues within 4Å: Chain A: A.115, L.118, L.119, L.207, I.210, A.211, G.241, C.242, P.243, V.246 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.118, A:L.119, A:A.211, A:V.246, A:V.246 Hydrogen bonds: A:G.241 Halogen bonds: A:L.207

4 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 2 residues within 4Å: Chain A: Y.10, K.12 Ligand excluded by PLIP CL.4: 3 residues within 4Å: Chain A: F.137, I.138 Ligands: STI.1 Ligand excluded by PLIP CL.5: 5 residues within 4Å: Chain A: F.95, M.96, T.97, G.150, E.151 Ligand excluded by PLIP CL.6: 4 residues within 4Å: Chain A: Y.31, G.99, N.100 Ligands: STI.1 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jahnke, W. et al., Binding or bending: distinction of allosteric Abl kinase agonists from antagonists by an NMR-based conformational assay. J.Am.Chem.Soc. (2010)

Release Date

2010-05-26

Peptides

Tyrosine-protein kinase ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase ABL1

Related Entries With Identical Sequence